Literature DB >> 11570508

Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype.

E Derby1, V Reddy, M Baseler, A Malyguine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11570508     DOI： 10.2144/01313dd03

Source DB:  PubMed          Journal:  Biotechniques        ISSN： 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  7 in total

Review 1.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

2.  Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.

Authors:  Ankan Gupta; Nishamol Geetha; Jiju Mani; Pramod Upadhyay; V M Katoch; M Natrajan; U D Gupta; Sangeeta Bhaskar
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

3.  THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.

Authors:  Meenakshi P Balakrishnan; Lucia Cilenti; Zineb Mashak; Paiyal Popat; Emad S Alnemri; Antonis S Zervos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

4.  A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.

Authors:  G G Kim; V S Donnenberg; A D Donnenberg; W Gooding; T L Whiteside
Journal:  J Immunol Methods       Date:  2007-06-28       Impact factor: 2.303

5.  CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia.

Authors:  S J Coles; E C Y Wang; S Man; R K Hills; A K Burnett; A Tonks; R L Darley
Journal:  Leukemia       Date:  2011-01-28       Impact factor: 11.528

6.  Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects.

Authors:  Supriya D. Mahajan; Ravikumar Aalinkeel; Stanley A. Schwartz; Ram P. Chawda; Madhavan P.N. Nair
Journal:  Biol Proced Online       Date:  2003-09-05       Impact factor: 3.244

7.  The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Authors:  Kimberly Shafer-Weaver; Thomas Sayers; Susan Strobl; Eric Derby; Tracy Ulderich; Michael Baseler; Anatoli Malyguine
Journal:  J Transl Med       Date:  2003-12-29       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.